Schedule 13G ownership disclosure

CARA THERAPEUTICS INC

Security class unavailable · CUSIP: 140755109

Event date: 2023-07-25

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
13.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-23-193487
Form type
SC 13G/A
Filer
Tvardi Therapeutics, Inc.
CIK
CIK 1346830
Filed
Jul 25, 2023
Reporting period
Jul 25, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub